Webinar: Interstitial Cystitis/Bladder Pain Syndrome: Current Diagnosis and Management - Future Trends (2020)

May 27, 2020

This course on IC/BPS is designed for the urologist, gynecologist, and advanced practice providers who see these patients and are responsible for their medical care. It is designed to focus on what we know, what we have learned from recent research efforts, how we can best use our knowledge in the care of these patients, and what may be coming in the future. We will discuss definition, nomenclature, epidemiology, possible etiology, and review the latest American Urological Association guideline which provides a working framework from which to practice. The issue of phenotyping, an important new focus on clinical trials, will be highlighted. We will review the major findings of the NIDDK Multidisciplinary Approach to the study of Pelvic Pain (MAPP) which is completing a decade of intensive research on this syndrome. How might this research inform and translate into the clinical arena and help our patients.

Please note this course is FREE to all AUA Members and is an exclusive member benefit.  If you would like to become an AUA Member, we'd be happy to have you - think about all the great member benefits!

Target Audience

  • Urologists
  • Residents
  • Advanced Practice Providers (Nurse Practitioners and Physician Assistants)

Learning Objectives

Upon completion of the activity, participants will be able to:

  1. Recall the AUA guidelines and describe how to apply them to care of their patients.
  2. Describe the major findings for the 10-year NIDDK MAPP research effort and its current and potential future impact on patient care.
  3. Determine how the syndrome is viewed in Europe and identifynew treatments and innovations that may impact care.
  4. Define the importance of phenotyping patients to improve outcomes.
  5. Recognize the controversy regarding whether Hunner lesions comprise a distinct disease.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Course opens: 
05/13/2020
Course expires: 
05/27/2023
Event starts: 
05/27/2020 - 5:00pm
Event ends: 
05/27/2020 - 6:30pm
Rating: 
0

SCIENTIFIC AGENDA:

Welcome, Housekeeping Notes
AUA

Introduction; Evolution of Definition of Interstitial Cystitis, Diagnosis
Philip Hanno MD, MPH

Phenotyping, the Hunner Lesion
Philip Hanno MD, MPH  

AUA Guideline, Conservative and Oral Rx                                                            
Philip Hanno MD, MPH 

Epidemiology, Pathology, and Etiology
Sandor Lovasz MD, PhD    

Intravesical Therapy
Sandor Lovasz MD, PhD                                                                           

European Approach to BPS                         
Sandor Lovasz MD, PhD

Neuromodulation, Botulinim Toxin, Surgery
J. Quentin Clemens MD

Confounding/Associated Disorders
J. Quentin Clemens MD

MAPP Research Network and Implications for the Future
J. Quentin Clemens MD

Interstitial Cystitis/Bladder Pain Syndrome: Current Diagnosis and Management - Future Trends (2020) will be held virtually on Wednesday, May 27 at 5 PM EST.

***Instructions***

  1. Click the "Register" tab.
  2. If prompted, click “update your profile”. Otherwise, click “Take Course”.
  3. Click "Participant Instructions" and then "Start". 

Education Council Disclosures

Education Council Disclosures

AUA Office of Education Staff has nothing to disclose.

Faculty disclosures will be posted here prior to the start of the course.

Course Director(s)

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this live activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


AUA Participant Information and Policies

DISCLAIMER:

The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

AUDIO, VIDEO AND PHOTOGRAPHIC EQUIPMENT:

The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meetings.

REPRODUCTION PERMISSION: 

Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

SPECIAL ASSISTANCE/DIETARY NEEDS:

The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Non-Physician Participation
Please login or register to take this course.

On the day of your webinar, simply return here to AUAUniversity to access your webinar and follow the steps below.  You will need your AUA ID Number and Password. You do not need to know the GoToWebinar access codes.

To join the webinar:

  1. Click on the TAKE COURSE button
  2. Review "Participant Instructions"
  3. Click “Start” under Live Webinar in the Course Progress pane. 
  4. Click "Join Webinar".